EP3412277
Þurrduftssamsetning sem inniheldur barkstera og beta-adrenvirkt efni til gjafar með innöndun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.1.2013EP published:
14.12.2022EP application number:
18181331.2
EP translation filed:
20.2.2023Grant published:
15.3.2023EPO information:
European Patent Register
Max expiry date:
22.1.2033Expiry date:
22.1.2027Next due date:
31.1.2027
Title in English:
DRY POWDER FORMULATION COMPRISING A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATIONLanguage of the patent:
English
Timeline
Today
23.1.2013EP application
14.12.2022EP Publication
20.2.2023Translation submitted
15.3.2023Registration published
22.1.2027Expires
Owner
Name:
Chiesi Farmaceutici S.p.A.Address:
Via Palermo, 26/A, 43122 Parma, IT
Inventor
Name:
MONARI, ElisaAddress:
43100 Parma, IT
Name:
CANTARELLI, Anna MariaAddress:
43100 Parma, IT
Name:
COCCONI, DanielaAddress:
43100 Parma, IT
Name:
PASQUALI, IreneAddress:
43100 Parma, IT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
12152392Date:
25.1.2012Country:
EP
Classification
Categories:
A61K 9/14, A61K 31/167, A61K 31/573, A61P 11/00, A61P 11/06
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 20.2.2023
Expires: 22.1.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 4.1.2024
Expires: 22.1.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.1.2025
Expires: 22.1.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.1.2026
Expires: 22.1.2027
Payer: Árnason Faktor ehf.